National Sarcoidosis Research Association(N S R A) is categorized under Medical Research in Houston, TX .
National Sarcoidosis Research Association(N S R A) was established in 0, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Stifina Ethridge at the company’s single location by writing to 1720 Dryden Road, Houston, Texas TX 77030 or by phoning (409) 397-4339. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | National Sarcoidosis Research Association(N S R A) |
Contact Person: | Stifina Ethridge |
Address: | 1720 Dryden Road, Houston, Texas 77030 |
Phone Number: | (409) 397-4339 |
Annual Revenue (USD): | $100.000 to $499.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
National Sarcoidosis Research Association(N S R A) was started in 0 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Stifina Ethridge for inquiries that concern National Sarcoidosis Research Association(N S R A) by calling the company number (409) 397-4339, as your correspondence is most welcome. Additionally, the physical location of the single location of National Sarcoidosis Research Association(N S R A) can be found at the coordinates as well as the street address 1720 Dryden Road in Houston, Texas 77030.
For its online presence, you may visit National Sarcoidosis Research Association(N S R A)’s website at and engage with its social media outlets through on Twitter and on Facebook.